3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
23
Breast
12
Thoracic
10
Gynecologic
7
Tumor-Agnostic
5
Other hematologic neoplasm
4
Other solid neoplasm
3
Lymphoid
3
Genitourinary
2
Plasma cell
1
Other
1
Head & Neck
1
Endocrine
1
Conditions
Multiple Myeloma
1
Lymphoma
1
Interventions
Cyclophosphamide
20
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
13
Dexamethasone
13
Cyclosporine
12
Whole-Body Irradiation
11
fludarabine
10
Exercise
10
Antilymphocyte Serum
10
Melphalan
9
Busulfan
9
Blood Specimen Collection
9
Mycophenolic Acid
8
Therapeutics
7
Filgrastim
7
Bortezomib
7
Standard of Care
6
Radiotherapy
6
Behavior Therapy
6
Acupuncture Therapy
6
pomalidomide
5
Specimen Handling
5
Palliative Care
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Educational Status
5
daratumumab
4
Surveys and Questionnaires
4
Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Patient Navigation
×
Plasma cell
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts